BN Business News
Add your company to Business Communicator →

Finanse publiczne · 02/01/2026

Statutory Updates to Branded Prescription Drug Fee Regulations

The proposed regulations update the annual fee imposed on covered entities manufacturing or importing certain branded prescription drugs, following changes to the Manufacturer Discount Program under the Inflation Reduction Act of 2022.

Source: Federal Register — Department of the TreasuryOpen original release →